COMP <GO>

CCEL vs VMD // FORWARD P/E MULTIPLE

Cryo-Cell International Inc. (NYSE) VS. Viemed Healthcare Inc. (NASDAQ) • 15-METRIC TALLY: CCEL 4 — VMD 3

■ METRIC PARITY

LAST: $5.19 (+1.17%) • MKT CAP: $41.8M

forward-pe

—

LAST: $9.95 (-0.40%) • MKT CAP: $379.0M

forward-pe

20.7x

15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (CCEL VS. VMD) EMERALD CELL = QUANTITATIVE EDGE

INSTITUTIONAL METRIC	CCEL	VMD	SPREAD (A - B)	ADVANTAGE	DEDICATED URL
Gross Profit Margin	—	57.50%	—	TIE	/gross-margins <GO>
Return on Invested Capital (ROIC)	18.20%	13.00%	+5.20	CCEL	/roic <GO>
EV/EBITDA & P/E Valuation	61.2x	6.6x	+54.60	VMD	/valuation <GO>
Free Cash Flow Yield	12.55%	3.15%	+9.40	CCEL	/fcf-yield <GO>
Operating Margin	—	8.50%	—	TIE	/operating-margins <GO>
Net Profit Margin	—	5.70%	—	TIE	/net-margins <GO>
Revenue Growth (YoY)	—	20.50%	—	TIE	/revenue-growth <GO>
Dividend Yield & FCF Payout Safety	7.73%	0.00%	+7.73	CCEL	/dividend-safety <GO>
Altman Z-Score & Debt/Equity	—	6.59	—	TIE	/balance-sheet <GO>
Piotroski F-Score Quality	3/9	9/9	-6.00	VMD	/piotroski-score <GO>
Options Implied Move & Put/Call Skew	—	—	—	TIE	/options-implied-move <GO>
RSI-14 & 200D SMA Momentum	64.3	53.1	+11.17	CCEL	/rsi-technicals <GO>
10Y Yield & FRED Macro Beta	—	—	—	TIE	/macro-sensitivity <GO>
Forward P/E Multiple ACTIVE	—	20.7x	—	TIE	/forward-pe <GO>
Enterprise Scale & Market Cap	$41.8M	$379.0M	-$337.2M	VMD	/market-cap <GO>

5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY

FISCAL YEAR	CCEL REV	VMD REV	CCEL GROSS %	VMD GROSS %	CCEL FCF	VMD FCF
FY 2025	$0	$270.3M	—	57.5%	$5.2M	$11.9M
FY 2024	$0	$224.3M	—	59.4%	$3.6M	$1.3M
FY 2023	$0	$183.0M	—	—	$8.9M	$45.2M

FRED MACRO REGIME CORRELATION COMPARISON PEARSON r

CCEL // BETA —

VMD // BETA —